Andere talen L&C Bio Co., Ltd

Aandelen

A290650

KR7290650001

slotkoers Korea S.E. Andere beurzen 00:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
19.650 ^KRW	-1,65%		-4,15%	-32,24%

2023	L&C Bio Co, Ltd (KOSDAQ:A290650) kondigt een aandeleninkoopprogramma aan voor 143.884 aandelen.	CI
2023	L&C BIO Co., Ltd keurt een terugkoopplan goed.	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ray Co., Ltd. announced that it has received KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.	27/03
Ray Co., Ltd. announced that it expects to receive KRW 25 billion in funding from KB Securities Co., Ltd., L&C Bio Co., Ltd, Samsung Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd., NH Investment & Securities Co., Ltd., Hanwha Investment & Securities Co., Ltd.	25/03
Plasmapp Co., Ltd. announced that it has received KRW 4.999997 billion in funding from DREAMTECH Co., Ltd., L&C Bio Co., Ltd	28/12
Plasmapp Co., Ltd. announced that it expects to receive KRW 4.999997 billion in funding from DREAMTECH Co., Ltd., L&C Bio Co., Ltd	21/12
Tranche Update on L&C Bio Co., Ltd's Equity Buyback Plan announced on November 23, 2023.	08/12
L&C Bio Co., Ltd's Equity Buyback announced on November 23, 2023, has closed with 143,884 shares, representing 0.63% for KRW 4,881 million.	30/11
L&C Bio Co., Ltd announces an Equity Buyback for 143,884 shares.	23/11
L&C BIO Co., Ltd authorizes a Buyback Plan.	23/11
L&C Bio Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023	15-05-23
Curexo Inc. announced that it has received KRW 40.49999982 billion in funding from L&C Bio Co., Ltd	30-06-22
L&C Bio Co., Ltd announced that it has received KRW 60 billion in funding	29-06-22
L&C Bio Co., Ltd announced that it expects to receive KRW 60 billion in funding	28-06-22
Curexo Inc. announced that it expects to receive KRW 40.49999982 billion in funding from L&C Bio Co., Ltd	23-05-22
NanoFocusRay Co., Ltd. announced that it expects to receive KRW 3.13 billion in funding from L&C Bio Co., Ltd	16-02-22
Netmarble : Skin care kiosk developer lululab secures funding	30-11-20
Lululab Inc. announced that it has received funding from L&C Bio Co., Ltd, Netmarble Corporation, CTK Investment Co., Ltd., Global Medical Research Center and other investors	10-11-20
Tranche Update on L&C BIO Co., LTD's Equity Buyback Plan announced on June 15, 2020.	25-06-20
L&C BIO Co., LTD's Equity Buyback announced on June 15, 2020, has closed with 91,996 shares, representing 1.25% for KRW 9,967.5 million.	24-06-20
L&C BIO Co., LTD announces an Equity Buyback for 91,996 shares.	15-06-20
L&C BIO Co., Ltd authorizes a Buyback Plan.	15-06-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen L&C Bio Co., Ltd

Aandelen

A290650

KR7290650001

Andere talen

Filters